DECIDE-HF: Heart Rate Variability in Heart Failure Patients
NCT ID: NCT00949676
Last Updated: 2013-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2009-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart Failure
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is 18 years of age or older
* Subject is expected to remain available for follow-ups
* Subject is able and willing to comply with the protocol requirements
* Subject has predominant Normal Sinus Rhythm
* Subject has systolic Heart Failure and is at the moment of enrollment in NYHA class II or III and has an ejection fraction of less then 40%
* Subject has had a HF-related hospitalization in the past 12 months
Exclusion Criteria
* Subject has intermittent 2nd or intermittent 3rd degree block
* Subject has persistent or permanent AF
* Subject has Long QT syndrome, Brugada syndrome, Jervell and Lange- Nielsen syndrome, Romano-Ward syndrome, Andersen-Tawil syndrome or Timothy's syndrome
* Subject has had recent (\<2 months) acute coronary syndrome
* Subject has had recent (\<2 months) revascularization
* Subject has a pending cardiac transplant or revascularization
* Subject has severe stenotic valvular heart disease
* Subject has severe pulmonary (forced expiratory volume in 1 s \< 1 L) hepatic or renal (plasma creatinine \> 0.2 mmol/L) disease
* Subject is participating in another study that may affect the results of this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic BRC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DECIDE HF Team
Role: STUDY_CHAIR
Medtronic BRC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antwerp, , Belgium
Kiel, , Germany
Munich, , Germany
Tübingen, , Germany
Leeds, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DECIDE-HF
Identifier Type: -
Identifier Source: org_study_id